Review Article | 30 Mar 2025

Legionnaires’ disease: A review of emerging public health threats

Aswin Rafif Khairullah1, Harimurti Nuradji1, Diana Nurjanah1, Ni Luh Putu Indi Dharmayanti1, Bantari Wisynu Kusuma Wardhani2, Syahputra Wibowo3, Ikechukwu Benjamin Moses4, Dea Anita Ariani Kurniasih5, Ima Fauziah1, Muhammad Khaliim Jati Kusala1, and Kartika Afrida Fauzia6Show more

1. Research Center for Veterinary Science, National Research and Innovation Agency, Jl. Raya Bogor, Km. 46 Cibinong, Bogor, 16911, West Java, Indonesia.

2. Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency, Jl. Raya Bogor, Km. 46 Cibinong, Bogor, 16911, West Java, Indonesia.

3. Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Jl. Raya Bogor, Km. 46 Cibinong, Bogor, 16911, West Java, Indonesia.

4. Department of Applied Microbiology, Faculty of Science, Ebonyi State University, Abakaliki, 480211, Nigeria.

5. Research Center for Public Health and Nutrition, National Research and Innovation Agency, Jl. Raya Bogor, Km. 46 Cibinong, Bogor, 16911, West Java, Indonesia.

6. Research Center for Preclinical and Clinical Medicine, National Research and Innovation Agency, Jl. Raya Bogor, Km. 46 Cibinong, Bogor, 16911, West Java, Indonesia.

Corresponding author: Ni Luh Putu Indi Dharmayanti (nlpdharmayanti@gmail.com)

Received: 2024-09-23, Accepted: 2025-02-07, Published: 2025-03-30

VETERINARY WORLD | pg no. 62-77 | Vol. 11, Issue 1 | DOI: 10.14202/vetworld.2025.62-77
Citations:

Cite this Article

  • APA
  • MLA
  • Chicago
  • Vancouver
  • Harvard

                
              

Abstract

Background and Aim: Legionnaires’ disease (LD), caused by the Gram-negative bacterium Legionella pneumophila, has emerged as a significant public health concern due to its rising incidence and high morbidity and mortality rates. This review comprehensively examines the etiology, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and prevention of LD. The bacterium thrives in aquatic environments, often within biofilms and protozoan hosts, contributing to its resilience and widespread distribution in natural and man-made water systems. Transmission primarily occurs through the inhalation of contaminated aerosols, with immunocompromised individuals, the elderly, and smokers being at heightened risk. Clinically, LD presents as a severe pneumonia with systemic involvement, and its diagnosis often relies on culture, urinary antigen tests, and molecular methods. The treatment landscape is dominated by macrolides and fluoroquinolones, with emerging research into alternative therapies to combat antimicrobial resistance. Effective public health strategies, including rigorous water management practices and infection control measures, are vital in mitigating the risk of outbreaks. This review aims to enhance clinical awareness and inform public health initiatives by elucidating the complex interplay between bacterial virulence, host factors, and environmental conditions that contribute to LD transmission and persistence. A better understanding of these dynamics is crucial for developing robust prevention and control strategies, ultimately reducing the global burden of this potentially life-threatening disease.

Keywords: Legionella pneumophila, Legionnaires’ disease, pneumonia, public health, waterborne pathogens.